LENZ Therapeutics, Inc. (LENZ)
NASDAQ: LENZ · Real-Time Price · USD
19.41
+0.02 (0.10%)
Jan 28, 2026, 8:05 AM EST - Market open
LENZ Therapeutics Market Cap
LENZ Therapeutics has a market cap or net worth of $607.34 million as of January 28, 2026. Its market cap has decreased by -4.85% in one year.
Market Cap
607.34M
Enterprise Value
405.49M
1-Year Change
-4.85%
Ranking
Category
Stock Price
$19.41
Market Cap Chart
Since the IPO on March 22, 2024, LENZ Therapeutics's market cap has increased from $413.64M to $607.34M, an increase of 46.83%. That is a compound annual growth rate of 23.05%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 27, 2026 | 606.71M | 21.19% |
| Dec 31, 2025 | 500.64M | -36.94% |
| Dec 31, 2024 | 793.95M | 91.94% |
| Mar 22, 2024 | 413.64M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Rigel Pharmaceuticals | 671.60M |
| MeiraGTx Holdings | 643.93M |
| ProKidney | 643.79M |
| Alpha Tau Medical | 624.99M |
| Altimmune | 617.82M |
| Evommune | 617.24M |
| Gossamer Bio | 615.67M |
| CorMedix | 611.40M |